Breast Unit, Department of Surgical Science, PTV Policlinico Tor Vergata University, Rome, Italy.
Breast Unit, Department of Surgical Science, PTV Policlinico Tor Vergata University, Rome, Italy;
Anticancer Res. 2023 Apr;43(4):1555-1562. doi: 10.21873/anticanres.16305.
BACKGROUND/AIM: Despite an aging population, there is no consensus regarding ductal carcinoma in situ (DCIS) treatment for elderly women. Breast surgery can be well tolerated even in elderly patients. The aim of this study is to evaluate the surgical management of DCIS in elderly patients.
We retrospectively analyzed patients with DCIS from 2016 to 2022 at our Breast Unit and divided our population according to age.
Out of 231 patients with DCIS, 45 (19.5%) were elderly. The Charlson comorbidity index and American Society of Anesthesiology (ASA) score was significantly higher in the elderly (p<0.001 for both). Among the elderly, 10 (22.2%) patients received upstaging diagnoses, versus 18 (9.7%) in the control (p=0.048). Twelve (26.7%) of the elderly patients underwent sentinel lymph node biopsy, versus 93 (50%) in the control group (p=0.005). No difference was reported between groups in terms of breast conserving surgeries performed. A higher incidence of surgeries performed using local anesthesia was reported in the elderly group (p=0.041). Thirty-day surgical complications, according to Clavien-Dindo, did not show significant differences.
Despite higher comorbidity and ASA score, breast surgery is safe and feasible in elderly patients. Due to the higher risk of upstaging to invasive ductal carcinoma, surgery should be performed but sentinel lymph node biopsy should be omitted, owing to the low risk of lymph node metastasis and lower use of adjuvant treatments.
背景/目的:尽管人口老龄化,但对于老年女性的导管原位癌(DCIS)治疗仍未达成共识。即使是老年患者,乳房手术也能很好地耐受。本研究旨在评估老年患者 DCIS 的手术治疗方法。
我们回顾性分析了 2016 年至 2022 年在我院乳腺科就诊的 DCIS 患者,并根据年龄对患者进行分组。
在 231 例 DCIS 患者中,45 例(19.5%)为老年患者。老年患者的 Charlson 合并症指数和美国麻醉医师协会(ASA)评分显著更高(均 p<0.001)。在老年患者中,有 10 例(22.2%)患者接受了升级诊断,而对照组中只有 18 例(9.7%)(p=0.048)。12 例(26.7%)老年患者行前哨淋巴结活检,而对照组中有 93 例(50%)(p=0.005)。两组保乳手术的比例无差异。老年组中局部麻醉手术的比例较高(p=0.041)。根据 Clavien-Dindo 分级,两组 30 天手术并发症无显著差异。
尽管合并症和 ASA 评分较高,但老年患者行乳房手术是安全可行的。由于升级为浸润性导管癌的风险较高,应进行手术,但应省略前哨淋巴结活检,因为淋巴结转移风险低,辅助治疗的应用率低。